网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
miRNA-21靶向调控子宫内膜癌PTEN基因MRE-21片段的研究
作者:孙利华1  汪蕾2 
单位:1. 广州军区总医院157临床部 妇产科, 广东 广州 510510;
2. 湖北中医药大学 检验学院, 湖北 武汉 430065
关键词:子宫内膜癌 微小RNA-21 PTEN基因 微小RNA反应-21片段 
分类号:R737.33
出版年·卷·期(页码):2017·36·第十期(1442-1446)
摘要:

目的:观察微小RNA-21(miR-21)对子宫内膜癌细胞PTEN基因的调控作用,并验证PTEN基因3'-UTR区内的微小RNA反应(MRE)-21片段为miR-21作用的靶向位点,为通过miR-21治疗子宫内膜癌提供依据。方法:在人子宫内膜癌HEC-1A细胞中转染不同浓度的miR-21拮抗剂、无关序列和空白对照,利用qRT-PCR法检测miR-21以及靶基因PTEN的mRNA水平,利用免疫印迹法检测PTEN的蛋白表达水平。再利用双荧光素酶报告基因法对miR-21与PTEN3'-UTR区内的MRE-21片段的靶向关系进行验证。结果:在HEC-1A细胞内,随着miR-21拮抗剂浓度的增加,miR-21的表达量逐步减少。miR-21拮抗剂组与无关序列组比较,miR-21表达量的减少差异有统计学意义(P<0.01);PTEN蛋白表达量的增加差异亦有统计学意义(P<0.01)。pMER-报告载体和miR-21拮抗剂共转染HEC-1A细胞时,与pMIR-空白载体转染组以及pMER-报告载体转染组相比,荧光素酶表达水平皆显著上调(P<0.01)。结论:沉默miR-21能上调子宫内膜癌细胞内PTEN基因的表达,PTEN基因3'-UTR区的MRE-21片段为miR-21作用的靶向位点。

参考文献:

[1] GARGIULO P,DELLA P C,BERARDI S,et al.Tumor genotype and immune microenvironment in POLE-ultramutated and MSI-hypermutated endometrial cancers:new candidates for checkpoint blockade immunotherapy?[J].Cancer Treat Rev,2016,48(1):61-68.
[2] 张楠,郑虹.子宫内膜癌的分子标记物在早期诊断中的作用[J].实用妇产科杂志,2015,31(7):493-495.
[3] OlIVETO S,MANCINO M,MANFRINI N,et al.Role of microRNAs in translation regulation and cancer[J].World J Biol Chem,2017,8(1):45-56.
[4] MELNIK B C.MiR-21:an environmental driver of malignant melanoma?[J].J Transl Med,2015,13(1):202.
[5] DONG J,ZHANG Z,GU T,et al.The role of microRNA-21 in predicting brain metastases from non-small cell lung cancer[J].Onco Targets Ther,2017,10:185-194.
[6] TSUJITA Y,MITSUI-SEKINAKA K,IMAI K,et al.Phosphatase and tensin homolog(PTEN) mutation can cause activated phosphatidylinositol 3-kinase delta syndrome-like immunodeficiency[J].J Allergy Clin Immunol,2016,138(6):1672-1680.
[7] PAPAGIANNAKOPOULOS T,SHAPIRO A,KOSIK K S.MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells[J].Cancer Res,2008,68(19):8164-8172.
[8] MERCADO-PIMENTE L,ONYEAGUCHA B C,LI Q,et al.The S100P/RAGE signaling pathway regulates expression of microRNA-21 in colon cancer cells[J].FEBS Lett,2015,589(18):2388-2393.
[9] DIRICAN E,AKKIPRIK M.Phosphatidylinositol 3-kinase regulatory subunit 1 and phosphatase and tensin homolog as therapeutic targets in breast cancer[J].Tumour Biol,2017,39(3):1-16.
[10] YADAV P,MIRZA M,NANDI K,et al.Serum microRNA-21 expression as a prognostic and therapeutic biomarker for breast cancer patients[J].Tumour Biol,2016,37(11):15275-15282.
[11] ASANGANI I A,RASHEED S A,NIKOLOVA D A,et al.MicroRNA-21(miR-21)post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion,intravasation and metastasis in colorectal cancer[J].Oncogene,2008,27(15):2128-2136.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 751786 位访问者


 ©《现代医学》编辑部
联系电话:025-83272481;83272479
电子邮件: xdyx@pub.seu.edu.cn

苏ICP备09058541